Trial intelligence / Profile preview

Roflumilast and Metformin for Weight Loss in Obese Women With PCOS

NCT02037672Phase 4Completed

Sponsor
University Medical Centre Ljubljana
Start
Sep 2013
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of roflumilast in obesity, polycystic ovary syndrome (PCOS), sponsored by University Medical Centre Ljubljana. Started Sep 2013; status: completed.

02

Drugs

roflumilast
03

Conditions

obesitypolycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT02037672.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02037672.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call